[144] CG Oncology, Inc. Common stock SEC Filing

Rhea-AI Filing Summary

CG Oncology, Inc. (CGON) reported a Form 144 notice indicating a proposed sale of 1,000 common shares by a person exercising stock options on 09/03/2025. The shares were acquired and paid for in cash on the same date through exercise of stock options from the issuer. The proposed sale lists Morgan Stanley Smith Barney LLC as the broker and an aggregate market value of $27,460 based on the filing. The filer also disclosed two prior 10b5-1 plan sales on 07/17/2025 totaling 2,000 shares with gross proceeds of $56,000. The form includes the standard representation that the seller is unaware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small option exercise and planned sale; disclosure shows orderly disposition, not material to cap structure.

The filing documents an insider exercise of stock options and a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney. Given the issuer's 76,247,581 shares outstanding and the reported aggregate market value of $27,460, the transaction is immaterial to overall capitalization. The disclosure of prior 10b5-1 sales (2,000 shares, $56,000) provides context on recent insider liquidity but does not indicate material dilution or financing activity.

Corporate Governance Expert

TL;DR: Filing reflects routine insider compliance and use of a 10b5-1 plan; no governance red flags apparent.

The Form 144 includes the required representations and notes reliance on Rule 10b5-1 for prior sales, suggesting the seller followed established procedures for planned dispositions. There is no disclosure of undisclosed material information and no indication of accelerated or unusual insider selling that would raise immediate governance concerns based on the provided figures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	27460.00	76247581	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2025	Exercise of Stock Options	Issuer			1000	09/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LEONARD E POST 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618	Common	07/17/2025	2000	56000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CGON disclose?

The Form 144 discloses a proposed sale of 1,000 common shares acquired by exercise of stock options on 09/03/2025, with Morgan Stanley Smith Barney as broker and an aggregate market value of $27,460.

When were the shares acquired and how were they paid for?

The 1,000 shares were acquired on 09/03/2025 by exercise of stock options and paid for in cash on the same date.

Did the filer report any sales in the past three months?

Yes. The filing discloses 10b5-1 sales on 07/17/2025 of 2,000 shares with gross proceeds of $56,000.

Who is the broker handling the proposed sale?

The named broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.

How many shares are outstanding for CGON according to the filing?

The filing reports 76,247,581 shares outstanding.